nimodipine has been researched along with Cochlear Hearing Loss in 7 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Susac's syndrome is an extremely rare clinical manifestation characterized by the triad of fluctuating sensorineural hearing loss, sudden visual loss and encephalopathy." | 2.41 | [Susac syndrome as a cause of sensorineural hearing loss]. ( Albaladejo Devis, I; Cubillana Herrero, JD; Jiménez Cervantes-Nicolás, JA; Minguez Merlos, N; Rodríguez González-Herrero, B; Soler Valcárcel, A, 2002) |
| "12 patients showed sudden deafness with a history of one day up to more than 20 years." | 1.27 | [Nimodipine (Bay e 9736) a new therapy concept in diseases of the inner ear?]. ( Theopold, HM, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Han, JJ | 2 |
| Lee, CK | 2 |
| Jung, JY | 1 |
| Park, KH | 1 |
| Lee, HY | 1 |
| Lee, BD | 1 |
| Choi, SJ | 1 |
| Cubillana Herrero, JD | 1 |
| Soler Valcárcel, A | 1 |
| Albaladejo Devis, I | 1 |
| Rodríguez González-Herrero, B | 1 |
| Minguez Merlos, N | 1 |
| Jiménez Cervantes-Nicolás, JA | 1 |
| Bischoff, B | 1 |
| Romstöck, J | 1 |
| Fahlbusch, R | 1 |
| Buchfelder, M | 1 |
| Strauss, C | 1 |
| Wildemann, B | 1 |
| Schülin, C | 1 |
| Storch-Hagenlocher, B | 1 |
| Hacke, W | 1 |
| Dithmar, S | 1 |
| Kirchhof, K | 1 |
| Jansen, O | 1 |
| Breitbart, A | 1 |
| Arellano, B | 1 |
| García Berrocal, JR | 1 |
| Górriz, C | 1 |
| González, FM | 1 |
| Vicente, J | 1 |
| Ramírez Camacho, R | 1 |
| Theopold, HM | 1 |
1 review available for nimodipine and Cochlear Hearing Loss
| Article | Year |
|---|---|
[Susac syndrome as a cause of sensorineural hearing loss].
Topics: Adult; Anti-Inflammatory Agents; Aspirin; Cerebral Infarction; Cochlea; Combined Modality Therapy; D | 2002 |
6 other studies available for nimodipine and Cochlear Hearing Loss
| Article | Year |
|---|---|
NIMODIPINE AND STEROID COMBINATION THERAPY FOR IDIOPATHIC SUDDEN SENSORINEURAL HEARING LOSS.
Topics: Audiometry, Pure-Tone; Dexamethasone; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Su | 2023 |
Nimodipine and Steroid Combination Therapy for Idiopathic Sudden Sensorineural Hearing Loss.
Topics: Audiometry, Pure-Tone; Dexamethasone; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Su | 2020 |
Intraoperative brainstem auditory evoked potential pattern and perioperative vasoactive treatment for hearing preservation in vestibular schwannoma surgery.
Topics: Adult; Brain Stem; Cochlear Nerve; Deafness; Evoked Potentials, Auditory, Brain Stem; Female; Follow | 2008 |
Susac's syndrome: improvement with combined antiplatelet and calcium antagonist therapy.
Topics: Adult; Aspirin; Calcium Channel Blockers; Cerebrovascular Disorders; Drug Combinations; Female; Hear | 1996 |
[Treatment protocol for sudden deafness].
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Audiometry, Pure-Tone; Child; Clinical Protocols; Heari | 1997 |
[Nimodipine (Bay e 9736) a new therapy concept in diseases of the inner ear?].
Topics: Adult; Aged; Auditory Threshold; Calcium Channel Blockers; Female; Hearing Loss, Noise-Induced; Hear | 1985 |